GeNeuro (CHIX:GNROP) ROE % Adjusted to Book Value : 0.00% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is GeNeuro ROE % Adjusted to Book Value?

GeNeuro's ROE % for the quarter that ended in Dec. 2023 was 0.00%. GeNeuro's PB Ratio for the quarter that ended in Dec. 2023 was N/A. GeNeuro's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.

GeNeuro ROE % Adjusted to Book Value Historical Data

The historical data trend for GeNeuro's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeNeuro ROE % Adjusted to Book Value Chart

GeNeuro Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-570.91

-9.26

-16.30

GeNeuro Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-13.37	-18.56	-12.04	-	-

Competitive Comparison of GeNeuro's ROE % Adjusted to Book Value

For the Biotechnology subindustry, GeNeuro's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GeNeuro's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeNeuro's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where GeNeuro's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

GeNeuro ROE % Adjusted to Book Value Calculation

GeNeuro's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

GeNeuro's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

GeNeuro ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of GeNeuro's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

GeNeuro Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (CHIX:GNROp) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228

Website

https://www.geneuro.com

GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).

GeNeuro Headlines

No Headlines